Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Varini

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer|August 1, 1985
Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancerM G Daidone, R Silvestrini, O Sanfilippo, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
A phase I trial of marcellomycin with a weekly dose scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Schweizerische Medizinische Wochenschrift|February 16, 1985
[Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia]V Hofmann, A Scheel, J Schwarzmeier, et al.
Clinical & Experimental Metastasis|April 1, 1983
T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.
Cancer Clinical Trials|January 1, 1981
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgeryM De Lena, M Varini, R Zucali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?M Castiglione-Gertsch, S Pampallona, M Varini, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer|August 1, 1985
Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancerM G Daidone, R Silvestrini, O Sanfilippo, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
A phase I trial of marcellomycin with a weekly dose scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Schweizerische Medizinische Wochenschrift|February 16, 1985
[Effect of interferon-alpha 2 (E. coli) in hairy cell leukemia]V Hofmann, A Scheel, J Schwarzmeier, et al.
Clinical & Experimental Metastasis|April 1, 1983
T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.
Cancer Clinical Trials|January 1, 1981
Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgeryM De Lena, M Varini, R Zucali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?M Castiglione-Gertsch, S Pampallona, M Varini, et al.
Pageof 2